U.S. Plans to Negotiate Drug Prices Face Fresh Industry Fire

The pharmaceutical industry’s largest trade group has filed a lawsuit challenging the constitutionality of President Biden’s drug-price negotiation law, the latest legal test of a program that could cost drugmakers billions of dollars over the next decade.